📢 DDReg Knowledge Capsule – Episode [21] Integration of Artificial Intelligence and the establishment of digital trust. It asserts that the pervasive use of AI in functions like pharmacovigilance and R&D has led to an erosion of digital trust, necessitating that automated systems be audited with the same rigor as traditional validated processes. Regulatory authorities now require demonstrable traceability and explainability from AI tools, prompting pharmaceutical firms to prove that algorithmic outputs meet necessary compliance standards. True AI auditability addresses five core areas, including data provenance and evidence of human oversight, though progress is complicated by unverified vendor claims and a lack of global harmonization. 
https://resource.ddregpharma.com/blogs/llifesciences-compliance-in-2025/